A Study to Evaluate the Efficacy and Safety of AD-224

Launched by ADDPHARMA INC. · Feb 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called AD-224 for people with essential hypertension, which is a common type of high blood pressure. The main goal of the study is to see how well AD-224 works and whether it is safe for patients. The trial is currently looking for participants who are aged 39 and older and who have been diagnosed with essential hypertension. To take part in the study, patients will need to provide their consent and meet specific health criteria.

Participants in this trial can expect to receive either the study drug or a placebo (a pill that looks like the real drug but has no active ingredients) to help researchers determine the effectiveness of AD-224. It is important to note that individuals with secondary hypertension, which is high blood pressure caused by another health issue, cannot participate. This study aims to gather valuable information that could help improve treatments for people living with high blood pressure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed informed consent
• • Patients with Essential Hypertension
• • Other inclusions applied
• Exclusion Criteria:
• • Patient with Secondary Hypertension
• • Other exclusions applied